RKDA · XBRL financial data

Arcadia Biosciences financial statements, every fiscal year

The same tables from 6 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

How these numbers work

Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
* marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
0 means a filing states zero; a dash (—) means no filing states that number.
“year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
Shares outstanding come from each filing's cover page, as of the date printed there.
Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

Fiscal years (RKDA's year ends in late December)

In thousands of dollars	FY 2020Dec 31, 2020	FY 2021Dec 31, 2021	FY 2022†Dec 31, 2022	FY 2023Dec 31, 2023	FY 2024Dec 31, 2024	FY 2025Dec 31, 2025
Revenue from contracts with customers	8,034	6,780	9,956	5,330	5,045	4,858
Cost of goods and services sold	5,199	8,708	9,802	3,300	2,963	3,098
Research and development	7,960	3,889	1,509	1,387	53	9
Selling, general and administrative	16,467	22,938	18,048	14,508	9,641	7,001
Total operating expenses	20,812	—	—	—	—	—
Operating income (loss)	(12,778)	(35,526)	(18,815)	(13,938)	(3,648)	(2,500)
Interest expense	47	20	—	—	—	—
Other income (expense)	740	10,114	33	48	31	2,309
Income tax expense (benefit)	(124)	2	14	8	8	8
Net income (loss)	(4,655)	(14,660)	(15,376)	(13,981)	(7,038)	(2,339)
Earnings per share, basic USD per share	—	(27.56)	(25.65)	(11.29)	(5.17)	(1.71)
Earnings per share, diluted USD per share	—	(27.56)	(25.65)	(11.29)	(5.17)	(1.71)
Weighted average shares, basic thousands of shares	—	532	599	1,237	1,363	1,368
Weighted average shares, diluted thousands of shares	—	532	599	1,237	1,363	1,368

† Share count changed about 1/26 in the period ending 2022-12-31, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.

Fiscal years (RKDA's year ends in late December)

In thousands of dollars	FY 2020Dec 31, 2020	FY 2021Dec 31, 2021	FY 2022†Dec 31, 2022	FY 2023Dec 31, 2023	FY 2024Dec 31, 2024	FY 2025Dec 31, 2025
Cash and cash equivalents	14,042	28,685	20,644	6,518	4,242	259
Short-term investments	11,625	—	0	5,124	0	4,304
Accounts receivable	1,406	1,370	—	—	—	—
Inventory	3,812	4,433	2,571	1,958	904	1,212
Prepaid and other current assets	811	900	809	807	931	156
Total current assets	31,696	35,388	25,398	14,972	9,242	6,356
Property and equipment, net	3,539	2,291	704	384	41	8
Right-of-use asset	5,826	3,081	1,848	792	137	0
Goodwill	408	—	—	—	—	—
Total assets	47,348	43,918	28,922	19,705	13,517	6,546
Total current liabilities	6,314	5,040	4,209	3,590	2,563	2,059
Long-term debt	2,105	0	—	—	—	—
Lease liability, non-current	5,389	2,220	1,007	155	0	—
Total liabilities	18,796	12,722	8,022	7,002	7,294	2,406
Accumulated deficit	(211,825)	(226,485)	(257,859)	(271,840)	(278,878)	(281,217)
Total stockholders' equity	27,725	31,093	21,033	12,841	6,223	—
Total liabilities and equity	47,348	43,918	28,922	19,705	13,517	6,546
Common shares outstanding (cover page) thousands of shares	21,336	22,189	858	1,363	1,367	2,057

† Share count changed about 1/26 in the period ending 2022-12-31, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.

Fiscal years (RKDA's year ends in late December)

In thousands of dollars	FY 2020Dec 31, 2020	FY 2021Dec 31, 2021	FY 2022†Dec 31, 2022	FY 2023Dec 31, 2023	FY 2024Dec 31, 2024	FY 2025Dec 31, 2025
Net income (loss)	(4,655)	(14,660)	(15,376)	(13,981)	(7,038)	(2,339)
Stock-based compensation	2,042	1,541	1,106	717	512	234
Net cash from operating activities	(30,218)	(25,868)	(13,977)	(15,294)	(9,627)	(4,739)
Purchases of property and equipment	2,335	1,007	72	5	16	0
Net cash from investing activities	17,284	16,608	1,417	(4,344)	7,342	750
Net cash from financing activities	20,560	21,900	4,519	5,512	9	6
Net change in cash	7,626	12,642	(8,041)	(14,126)	(2,276)	(3,983)

† Share count changed about 1/26 in the period ending 2022-12-31, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.

SIC 1311 and related industry codes, similar size. Each row is the latest quarter reported.

How peers are chosen

SIC 1311 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
Runway shows only for companies burning cash with under $10B of public float.
* marks a quarter worked out from the filing totals: for a 10-K, the year less the first three quarters; for a 10-Q, the year-to-date total less the earlier one.
A cell reading “not reported” means the filings give no figure for that quarter alone.

Company	Cash ($K)	Revenue, quarter ($K)	Operating cash flow, quarter ($K)	Shares outstanding	Runway	Quarter
Arcadia Biosciences	4,178	1,443	(319)*	2.4M	13.1 quarters	Q2 FY26 10-QJun 30, 2026
New Concept Energy	304	41	(14)*	5.1M	21.7 quarters	Q2 FY26 10-QJun 30, 2026
Barnwell Industries	4,467	3,379	not reported	14.4M	—	Q3 FY26 10-QJun 30, 2026
Battalion Oil	83,097	48,129	8,778*	57.3M	—	Q2 FY26 10-QJun 30, 2026
Viking Global Technologies	394	0	(399)*	281.8M	1.0 quarters	Q2 FY26 10-QJun 30, 2026
Trio Petroleum	23,204	349	(397)*	5.3M	27.3 quarters	Q3 FY26 10-QJul 31, 2026
Mexco Energy	1,293	1,983	1,451	2.0M	—	Q1 FY27 10-QJun 30, 2026
Okmin Resources	22	0*	15*	128.5M	—	Q4 FY26 10-KJun 30, 2026
Blue Dolphin Energy	30,715	144,255	38,202*	14.9M	—	Q2 FY26 10-QJun 30, 2026

Not investment advice. Not affiliated with the U.S. SEC.